Establishing Health Biotech and Enhancing Local Manufacturing of Pharmaceuticals in Sub-Saharan Africa
Although many nations in Sub-Saharan Africa (SSA) have recently recorded impressive economic growth, and several countries could attain middle-income status in the next decade, there is no or little concurrent advance in health biotech with little capabilities for manufacturing of medicines, medical...
Saved in:
Main Author: | Taye T Balcha MD, MPH, PhD (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2018-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Infotech and biotech: learning the lessons
by: Richard G.A. Feachem -
Drafting eligible biotech and immunotherapy claims
by: Shyh-Jen Wang
Published: (2019) -
COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa
by: Bisi Bright, et al.
Published: (2021) -
Fistula in sub-Saharan Africa
by: Karen Ballard, et al.
Published: (2015) -
Hepatitis B in Sub-Saharan Africa
by: Jessica Howell, et al.
Published: (2014)